drugset / Trial / NCT04484402
Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells
Phase 1/2
Completed
25 enrolled
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Belarusian State Medical University · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Treatment of patients with inflammatory-dystrophic diseases of the cornea using autologous limbal stem cells (corneal epithelial stem cells) or adipose-derived mesenchymal stem cells
Timeline
- Start
- 2016-10-03
- Primary completion
- 2019-12-30
- Completion
- 2019-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | limbal stem cells | Cell therapy | — | Other |
| Subject | mesenchymal stem cells | Cell therapy | — | Other |